Vasundara Venkateswaran

University of Toronto — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index2.5kcitations82works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Lipids, and Metabolism(33), Prostate Cancer Treatment and Research(26), Prostate Cancer Diagnosis and Treatment(10), Metabolism, Diabetes, and Cancer(10), Diet and metabolism studies(9)

Publications81 total

The impact of topical tranexamic acid on drain duration and seroma volume in axillary lymph node dissection for breast cancer: A randomized controlled trial
World Journal of Surgery·2024Open Access
Abstract B046: Multimodal biomarkers that predict the presence of Gleason pattern 4: Potential impact for active surveillance
Cancer Research·2023
Febrile neutropenia in paediatric hemato-oncology – The role of healthcare providers in the golden hour and beyond
Pediatric Hematology Oncology Journal·2023Open Access
Multimodal biomarkers overcome sampling bias to predict presence of aggressive localized prostate cancer.
Journal of Clinical Oncology·2021
Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci
The Prostate·2019· 13 cited
Abstract 4805: Cannabinoid WIN 55,212-2 induces endoplasmic reticulum stress in prostate cancer cells through CB1and CB2receptors
Cancer Research·2019
Abstract 4805: Cannabinoid WIN 55,212-2 induces endoplasmic reticulum stress in prostate cancer cells through CB<sub>1</sub>and CB2receptors
Experimental and Molecular Therapeutics·2019
Combining Desmopressin and Docetaxel for the Treatment of Castration-Resistant Prostate Cancer in an Orthotopic Model
Anticancer Research·2018· 12 citedOpen Access
Cannabinoid WIN 55,212‐2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid‐receptor 2 dependent manner
The Prostate·2018· 58 cited
Abstract 5878: Effect of cannabinoid WIN 55,212-2 on prostate cancer cell proliferation, migration, invasion, and tumor growth
Cancer Research·2018· 1 cited
Personalized risk stratification for patients with early prostate cancer (PRONTO): A Canadian team biomarker project.
Journal of Clinical Oncology·2018
Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillance
Prostate Cancer and Prostatic Diseases·2017· 11 cited
Evaluating Metformin as a Potential Chemosensitizing Agent when Combined with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Cells
Anticancer Research·2017· 8 citedOpen Access
Abstract 8: Anandamide reduces cell migration, invasion, and induces apoptosis in an <i>in vitro</i> model of prostate cancer
Cancer Research·2017· 1 cited
MP83-17 EFFECT OF COMBINATION THERAPY OF DESMOPRESSIN AND DOCETAXEL ON PROSTATE CANCER CELL DU145 PROLIFERATION, MIGRATION AND GROWTH
The Journal of Urology·2017
Effect of Combination therapy of Desmopressin and Docetaxel on prostate cancer cell DU145 proliferation, migration and growth
Journal of Cancer Biology and Therapeutics·2016· 1 citedOpen Access
The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer
The Journal of Urology·2016· 37 cited
Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance
The Journal of Urology·2016· 49 cited
Abstract 1434: Diabetic metastatic castration-resistant prostate cancer patients administered metformin during docetaxel chemotherapy have improved prostate cancer-specific and overall survival
Cancer Research·2016· 1 cited
A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells
Biochemical and Biophysical Research Communications·2015· 31 cited
page 1 of 5Next →

Frequent Co-authors

Laurence Klotz(42), Neil Fleshner(27), Linda Sugar(16), Natalie A. Venier(14), Robert K. Nam(9), Alexandra Colquhoun(7), Steven A. Narod(6), Domenica Roberto(6), Andrew Loblaw(5), Aleksandra Stanimirovic(4), John Trachtenberg(4), Mireía Musquera(4), Michaël Pollak(4), M Mayer(4), Alex Kiss(3), William Zhang(3), Ants Toi(3), Avi Vandersluis(3), Arun Seth(2), D. Andrew Loblaw(2)